Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Scientific Corp (NYSE:BSX)

28.77
Delayed Data
As of 3:59pm ET
 -0.075 / -0.26%
Today’s Change
19.67
Today|||52-Week Range
29.40
+32.99%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Mahoney Michael F
Chairman, President & Chief Executive Officer
Sale2/28/2017160,565$24.55$3.9M+17.47%
Mahoney Michael F
President & Chief Executive Officer
Sale11/01/2016160,756$21.71$3.5M+32.84%
Brennan Daniel J /boston/
Chief Financial Officer & Executive Vice President
Sale7/11/201792,158$27.48$2.5M+4.76%
Dawkins Keith D
Exxecutive Vice President
Sale2/07/201780,783$25.21$2.0M+14.31%
Phalen Michael P
President-Medsurg & EVP
Sale3/29/201779,045$24.55$1.9M+16.71%
Mahoney Michael F
President & Chief Executive Officer
Sale1/01/201763,106$21.63$1.4M+31.81%
Phalen Michael P
President-Medsurg & EVP
Sale4/26/201734,773$26.00$904.1K+11.05%
Nanavaty Maulik K
SVP & President-Neuromodulation
Sale8/31/201730,000$27.45$823.5K+4.68%
Dawkins Keith D
Exxecutive Vice President
Sale2/28/201730,000$24.64$739.2K+17.47%
Nanavaty Maulik K
SVP & President-Neuromodulation
Sale8/30/201727,031$27.08$732.0K+6.50%
Page of 28